ARWR stock forecast
Our latest prediction for Arrowhead Pharmaceuticals Inc.'s stock price was made on the Oct. 22, 2021 when the stock price was at 66.03$.
In the short term (2weeks), ARWR's stock price should underperform the market by -2.01%. During that period the price should oscillate between -8.41% and +7.22%.
In the medium term (3months), ARWR's stock price should underperform the market by -6.21%. During that period the price should oscillate between -29.64% and +18.30%.Get email alerts
Create a solid portfolio with ARWR
About Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.
At the moment the company generates 108M USD in revenues.
On its last earning announcement, the company reported a loss of -1.23$ per share.
The book value per share is 1.15$
Three months stock forecastOct. 22, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|